IL-6 is susceptible to production induced by TNF-α, which can worsen hepatic steatosis, insulin resistance, and inflammation in the pathogenesis of NAFLD, thereby facilitating the onset and progression of the disorder (Cengiz et al., 2014). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.